Basiliximab Induction with Reduced Dose Mycophenolate in Simultaneous Liver-Kidney Transplant Recipients

被引：0
|
作者：
Zaver, A. [1 ]
Brown, A. [1 ]
Winstead, R. [1 ]
Lee, S. [2 ]
机构：
[1] Virginia Commonwealth Univ Hlth, Pharm, Richmond, VA USA
[2] Virginia Commonwealth Univ Hosp, Transplant Surg, Richmond, VA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
CLB26
引用
收藏
页码：S1010 / S1010
页数：1
相关论文
共 50 条
  • [41] Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methyl prednisolone effectively prevent acute rejection in kidney transplant recipients
    Kovac, D
    Kotnik, V
    Kandus, A
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4230 - 4234
  • [42] Simultaneous Liver-Kidney (SLK) Transplant with Steroid Free Immunosuppression After Rabbit Antithymocyte Globulin Induction
    Helmick, Ryan
    Hall, David
    Ly, Eric
    Podilla, Pradeep
    Vanatta, Jason
    Eason, James
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 76 - 76
  • [43] Propensity Score-Based Survival Benefit of Simultaneous Liver-Kidney Transplant Over Liver Transplant Alone for Recipients With Pretransplant Renal Dysfunction
    Sharma, Pratima
    Shu, Xu
    Schaubel, Douglas E.
    Sung, Randall S.
    Magee, John C.
    [J]. LIVER TRANSPLANTATION, 2016, 22 (01) : 71 - 79
  • [44] Patient Outcomes Following the Disappearance of Donor Specific Antibody in Crossmatch Positive Simultaneous Liver-Kidney Transplant Recipients
    Jindra, P.
    Stacie, G.
    Rana, A.
    O'Mahony, C.
    Goss, J.
    Bhamidipati, M.
    Whiston, E.
    Kerman, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 772 - 772
  • [45] Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients
    Haririan, A
    Morawski, K
    Sillix, DH
    El-Amm, JM
    Garnick, J
    West, MS
    Granger, DK
    Migdal, SD
    Gruber, SA
    [J]. TRANSPLANTATION, 2005, 79 (06) : 716 - 721
  • [46] Clinical Outcomes of Kidney Transplant Recipients by Steroid Early Withdraw Protocol with Basiliximab Induction
    Takada, Y.
    Hotta, K.
    Iwami, D.
    Higuchi, H.
    Hirose, T.
    Sasaki, H.
    Shinohara, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 576 - 576
  • [47] Basiliximab in paediatric liver-transplant recipients
    Vester, U
    Kranz, B
    Treichel, U
    Hoyer, PF
    [J]. LANCET, 2001, 357 (9253): : 388 - 389
  • [48] Incidence of Infectious Complications in Kidney Transplant Recipients Receiving Induction with Basiliximab, Thymoglobulin or Both
    Jankovic, J.
    Pascual, M.
    Venetz, J. -P.
    Nseir, G.
    Meylan, P.
    Manuel, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 323 - 323
  • [49] Single-Dose Basiliximab Induction in Low-Risk Renal Transplant Recipients
    Cunningham, Kathleen C.
    Hager, David R.
    Fischer, Jessica
    D'Alessandro, Anthony M.
    Leverson, Glen E.
    Kaufman, Dixon B.
    Djamali, Arjang
    [J]. PHARMACOTHERAPY, 2016, 36 (07): : 823 - 829
  • [50] SIMULTANEOUS LIVER-KIDNEY TRANSPLANT. SIXTEEN YEARS OF MONOCENTRIC EXPERIENCE
    Ferrari, Annachiara
    Mori, Giacomo
    Alfano, Gaetano
    Di Sandro, Stefano
    Di Benedetto, Fabrizio
    Cappelli, Gianni
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345